Lucintel’s latest market report analyzed that HER2 antibody provides attractive opportunities in hospitals and medical centers. The HER2 antibody market is expected to grow at a CAGR of 8%-10%. In this market, trastuzumab is the largest segment by type of treatment drugs.
Download Brochure of this report by clicking on https://www.lucintel.com/her2-antibody-market.aspx
Based on type of treatment drugs, the HER2 antibody market is segmented into trastuzumab, lapatinib, ado-trastuzumab emtansine, pertuzumab, and everolimus. The trastuzumab segment accounted for the largest share of the market in 2020 due to increasing prevalence of cancer.
Browse in-depth TOC on “HER2 Antibody Market”
XX – Tables
XX – Figures
The HER2 antibody market is marked by the presence of several big and small players. Some of the prominent players offering HER2 antibody include Roche, Novartis, Abnova, Pfizer, InvivoGen, Biocon, Bio-Techne, Samsung Bioepis and Celltrion.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link email@example.com.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.